Notice Type
Departmental
Provisional Consent to the Distribution of a New Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto: Schedule Trade Name: Relenza Rotadisk Dosage Form: Powder for inhalation Active Ingredient: Zanamivir 5 mg Manufacturer(s): Glaxo Wellcome Australia Limited, Boronia, Victoria, AUSTRALIA and Glaxo Wellcome Production, Evreux, FRANCE. Note: This consent is valid for 2 years from the date of publication of this notice. Dated this 22nd day of June 1999. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
Publication Date
24 Jun 1999

Notice Number

1999-go4608

Page Number

1683